According to The Insight Partners market research study titled “Transient Protein Expression Market to 2027 – COVID-19 Impact and Global Analysis – by Product Type, Application, and End User,” the global transient protein expression market is expected to reach US$ 983.10 million by 2027 from US$ 660.00 million in 2019. The market is estimated to grow at a CAGR of 5.3% from 2020 to 2027. The report highlights the trends prevalent in the global transient protein expression market and the factors driving the market along with those that act as deterrents to its growth.
Request Sample Copy of Xyz Market research report at – https://www.theinsightpartners.com/sample/TIPRE00017081/
Based on product type, the transient protein expression market is segmented into instruments, reagents, vectors, and competent cells. In 2019, the instruments segment held the largest market share. This segment is also expected to dominate the market during the forecast period as instruments are reducing human input which enables continuous cell maintenance and protein production. Moreover, the same segment is anticipated to grow at the fastest rate during the forecast period.
Driving factors, such as increasing applications of protein expression and growing adoption of precision medicines, are expected to boost the market growth over the years. However, high cost of products is likely to pose a negative impact on the market growth.
The coronavirus pandemic is estimated to have significant impact on the transient protein expression market. Majority of the pharmaceutical companies around the globe are engaged in the development of vaccines for coronavirus. However, this shift of focus is anticipated to have a negative impact on the other segments of the market. Also, disruptions in supply chain caused due to halt in global operations are projected to have an adverse impact on the market.
Prominent players operating in transient protein expression market include THERMO FISHER SCIENTIFIC INC.; MERCK KGaA; QIAGEN; GenScript; Promega Corporation; Takara Bio Inc.; MERIDIAN BIOSCIENCE, INC.; New England Biolabs; Agilent Technologies, Inc.; Mirus Bio LLC; and Sino Biological Inc.
The market players are focused toward bringing new and innovative products and services to sustain their position in the market. For instance, in September, 2017, Thermo Fisher Scientific Inc. launched its new PureLink Fast Low-Endotoxin Plasmid Purification Midi and Maxi Kits, which significantly reduce plasmid purification time to accelerate protein expression. Such developments are expected to help the market grow during the forecast period.
The report segments the global transient protein expression market as follows:
Global Transient Protein Expression Market – by Product Type
Global Transient Protein Expression Market – by Application
Global Transient Protein Expression Market – by End User
Global Transient Protein Expression Market – by Geography
Order a copy of this research Xyz Market research report at – https://www.theinsightpartners.com/buy/TIPRE00017081/